Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...
Study results show that patients with chronic obstructive pulmonary disease (COPD) and comorbid asthma may have a greater risk of hospitalization from COVID-19 if they use bronchodilators or steroids ...
In an analysis adjusted for tobacco cigarette use, the likelihood for asthma and COPD significantly rose with daily cannabis ...
Zacks Investment Research on MSN
GSK's Nucala for COPD and Depemokimab for asthma get CHMP nod in EU
GSK plc GSK announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) ...
In the 12 months after starting tezepelumab, patients with severe asthma had fewer exacerbations, a lower cumulative oral ...
—According to findings of a large study of patient care in England and Wales, hospitalized patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma have different ...
—A London-based research team tapped tens of thousands of records to determine the risk of dying from respiratory disease among people with asthma, chronic obstructive pulmonary disease (COPD), or a ...
A study found that chronic obstructive pulmonary disease (COPD) and asthma were not risk factors for ICU admission or death as a result of SARS-CoV-2 infection. The study contradicts the widely ...
A high-pitched whistling sound when you breathe is the first tip-off that air is fighting to make its way into or out of your lungs. That sound is aptly named wheezing, and it is something that people ...
The arrival of cold weather can exacerbate the condition, causing difficulty in breathing due to airway irritation, pollution and viral infections. In winter, a lot of patients have frequent wheeze, ...
Dr. Bruce Bochner answers the question: 'Difference Between COPD And Asthma?' — -- Question:What is the difference between asthma and COPD (Chronic Obstructive Pulmonary Disease)? Answer: So, ...
GSK’s depemokimab, a long-acting biologic that’s key in the British pharma’s growth plan, has won an endorsement from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback